Baillie Gifford & Co’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167M | Sell |
|
|||||
|
2025
Q1 | $164M | Sell |
|
|||||
|
2024
Q4 | $251M | Sell |
|
|||||
|
2024
Q3 | $389M | Sell |
|
|||||
|
2024
Q2 | $320M | Sell |
|
|||||
|
2024
Q1 | $288M | Sell |
|
|||||
|
2023
Q4 | $306M | Sell |
|
|||||
|
2023
Q3 | $303M | Sell |
|
|||||
|
2023
Q2 | $438M | Sell |
|
|||||
|
2023
Q1 | $354M | Buy |
|
|||||
|
2022
Q4 | $420M | Buy |
|
|||||
|
2022
Q3 | $452M | Sell |
|
|||||
|
2022
Q2 | $438M | Sell |
|
|||||
|
2022
Q1 | $482M | Sell |
|
|||||
|
2021
Q4 | $672M | Buy |
|
|||||
|
2021
Q3 | $757M | Sell |
|
|||||
|
2021
Q2 | $1.19B | Buy |
|
|||||
|
2021
Q1 | $742M | Buy |
|
|||||
|
2020
Q4 | $1.02B | Buy |
|
|||||
|
2020
Q3 | $388M | Buy |
|
|||||
|
2020
Q2 | $224M | Buy |
|
|||||
|
2020
Q1 | $160M | Buy |
|
|||||
|
2019
Q4 | $132M | Buy |
|
|||||
|
2019
Q3 | $113M | Sell |
|
|||||
|
2019
Q2 | $154M | Buy |
|
|||||
|
2019
Q1 | $145M | Buy |
|
|||||
|
2018
Q4 | $129M | Buy |
|
|||||
|
2018
Q3 | $119M | Buy |
|
|||||
|
2018
Q2 | $81.5M | Buy |
|
|||||
|
2018
Q1 | $102M | Buy |
|
|||||
|
2017
Q4 | $77M | Buy |
|